Carbetapentane citrate 20 mg / potassium guaiacolsulfonate 45 mg / phenylephrine HCl 10 mg / phenylpropanolamine HCl 10 mg Oral Tablet
RxNorm 725820
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 725820 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: carbetapentane citrate 20 mg / potassium guaiacolsulfonate 45 mg / phenylephrine HCl 10 mg / phenylpropanolamine HCl 10 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Carbetapentane citrate 20 mg / phenylephrine hydrochloride 10 mg / phenylpropanolamine hydrochloride 10 mg / potassium guaiacolsulfonate 45 mg Oral Tablet
(Atom ID: 12422350)
SY
Synonym (SY):
Carbetapentane citrate 20 mg / phenylephrine hydrochloride 10 mg / phenylpropanolamine hydrochloride 10 mg / K+ guaiacolsulfonate 45 mg Oral Tablet
(Atom ID: 12424623)
SY
Synonym (SY):
Carbetapentane citrate 20 mg / phenylephrine hydrochloride 10 mg / phenylpropanolamine hydrochloride 10 mg / Pot guaiacolsulfonate 45 mg Oral Tablet
(Atom ID: 12424624)
PSN
Prescribable Name (PSN):
Carbetapentane citrate 20 mg / potassium guaiacolsulfonate 45 mg / phenylephrine HCl 10 mg / phenylpropanolamine HCl 10 mg Oral Tablet
(Atom ID: 12422352)
SY